Edition:
United States

Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

40.34USD
27 Mar 2017
Change (% chg)

$0.66 (+1.66%)
Prev Close
$39.68
Open
$40.01
Day's High
$40.37
Day's Low
$39.93
Volume
44,663
Avg. Vol
61,204
52-wk High
$54.70
52-wk Low
$39.04

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 28 Mar 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-17 2 139,639.00 142,622.00 136,656.00 173,131.00
Year Ending Mar-18 2 154,999.00 157,130.00 152,868.00 --
Earnings (per share)
Year Ending Mar-17 2 78.12 78.52 77.73 149.36
Year Ending Mar-18 2 110.06 114.31 105.82 --
LT Growth Rate (%) 1 12.70 12.70 12.70 10.20

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-13 34,304.20 35,607.60 1,303.38 3.80
Quarter Ending Sep-13 33,274.40 32,915.40 359.00 1.08
Quarter Ending Jun-13 30,208.40 28,377.70 1,830.79 6.06
Quarter Ending Mar-13 30,278.20 33,592.40 3,314.19 10.95
Quarter Ending Dec-12 33,670.60 28,133.20 5,537.37 16.45
Earnings (per share)
Quarter Ending Dec-13 27.59 33.67 6.08 22.03
Quarter Ending Sep-13 27.86 39.84 11.98 43.02
Quarter Ending Jun-13 23.85 21.37 2.48 10.39
Quarter Ending Mar-13 29.10 32.88 3.78 12.98
Quarter Ending Dec-12 30.21 21.56 8.65 28.64

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-17 139,639.00 144,819.00 144,819.00 147,063.00 173,131.00
Year Ending Mar-18 154,999.00 166,382.00 166,382.00 169,687.00 --
Earnings (per share)
Year Ending Mar-17 78.12 80.82 80.82 84.50 149.36
Year Ending Mar-18 110.06 137.74 137.74 142.94 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-17 0 2 0 2
Year Ending Mar-18 0 2 0 2
Earnings
Year Ending Mar-17 0 2 0 2
Year Ending Mar-18 0 2 0 2

More From Around the Web